ProteinQure

Dare to Deliver

Headquarters
Toronto
Business Model
B2B
Last Round
Series AMay 2025
Rounds
2

About

ProteinQure is a clinical-stage biotech company based in Toronto's life sciences hub, designing novel exotic peptides using atomic-level biophysics simulations and AI. The company's multidisciplinary team combines machine learning, computational biology, and experimental science to develop peptide therapeutics such as PQ203, the first AI-designed peptide to enter Phase I clinical trials, and has raised Series A financing to advance its pipeline.

Summary

ProteinQure is an Artificial Intelligence company based in Toronto, Canada. Its most recent funding was a Series A round in May 2025. Investors include Heron Rock Fund, Felicis Ventures and 8VC.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2025

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ProteinQure on Indexed.vc
<a href="https://indexed.vc/companies/proteinqure"><img src="https://indexed.vc/api/badge/company/proteinqure" alt="ProteinQure on Indexed.vc" width="260" height="76" /></a>